Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide in Chronic Kidney Failure
NCT07176663Not yet recruiting
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2026
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial in obesity and type 2 diabetes mellitus (T2DM), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Weight loss at 3 months. Planned start Feb 2026; status: not yet recruiting.
02
Conditions
obesitytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07176663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07176663.